Skip to content

Study of Effects of Light on the Vigilance and Cognitive Performance Following a Night Without Sleep

Study of Effects of Light on the Vigilance and Cognitive Performance Following a Night Without Sleep

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02478528
Acronym
LUMI
Enrollment
18
Registered
2015-06-23
Start date
2015-05-31
Completion date
2015-06-30
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

Sleep disorders are a major public health issue, affecting 1 in 6 French. The medical impact at the individual level but also social and economic level (loss of productivity, morbidity, mortality) emphasize the need for one hand, to improve the investigators' understanding of these disorders in order to develop appropriate therapeutic tools and on the other hand, to increase the investigators' support abilities of patients with these disorders. The investigators' team of unity sleep from Strasbourg University Hospitals, in collaboration with the UPR 3212 CNRS team, is working on the development and adjustment of new concepts and tools to compensate the investigators' sleep debt in order to apply them to patients with sleep disorders and persons who face with sleep restriction.

Interventions

DEVICEEnergy-Light lamp

Exposure of the subject, at 5am, to the light source of Energy-Light lamp (Philips)

DEVICELuminettes lamp

Exposure of the subject, at 5am, to the light source of Luminettes lamp (Lucimed)

OTHERcontrol condition

No exposure of the subject to any light sources (control condition)

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Man or woman * Age from 18 to 40 years * With a Body Mass Index (BMI) between 17 and 30 kg m-2 * Healthy volunteer determined by clinical examination and psychological interview * Agreeing to abstain from caffeine, nicotine, alcohol, psychotropic drugs, cannabis or other drugs, the week before the start of Stage 2 of the study until the end of the study * Dated and signed informed consent * Subjet affiliated to a social security scheme * Subject has been informed about the results of the medical examination

Exclusion criteria

* Participation in other clinical trials in the month preceding the inclusion * Shift work in the year before inclusion * Cons-indications to the use of the medical device * Ocular disease * Unable to give informations to the subject (subject in an emergency situation, difficulties in understanding, ...) * Subjet under judicial protection * Subject under guardianship or curatorship * pregnancy * breastfeeding

Design outcomes

Primary

MeasureTime frameDescription
Analysis of the perception of fatigueCompare during the 3 sessions : energy-light lamp, luminettes lamp and control conditionKarolinska Sleepiness Scale 3 sessions :
Analysis of the circadian variation of melatonin and cortisol secretionCompare during the 3 sessions : energy-light lamp, luminettes lamp and control conditioncortisol and melatonin dosage

Secondary

MeasureTime frameDescription
Cognitive performanceCompare during the 3 sessions : energy-light lamp, luminettes lamp and control conditionneurobehavioral tests

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026